eFFECTOR Therapeutics, Inc. (EFTR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -22.91 Million USD | -754.83% |
| 2022 | 3.5 Million USD | 148.93% |
| 2021 | 1.4 Million USD | -93.03% |
| 2020 | 20.16 Million USD | 6669.38% |
| 2019 | -307 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -28 Thousand USD | -121.21% |
| 2023 Q3 | -26 Thousand USD | 3.7% |
| 2023 FY | -111 Thousand USD | -103.17% |
| 2023 Q4 | 132 Thousand USD | 607.69% |
| 2023 Q2 | -27 Thousand USD | 3.57% |
| 2023 Q1 | -28 Thousand USD | -104.32% |
| 2022 Q4 | 648 Thousand USD | 0.0% |
| 2022 Q1 | -5000.00 USD | -100.35% |
| 2022 Q3 | - USD | -100.0% |
| 2022 FY | 3.5 Million USD | 148.93% |
| 2022 Q2 | 2 Million USD | 40260.0% |
| 2021 FY | 1.4 Million USD | -93.03% |
| 2021 Q3 | 421 Thousand USD | 112.46% |
| 2021 Q2 | -3.38 Million USD | -48185.71% |
| 2021 Q1 | -7000.00 USD | 99.85% |
| 2021 Q4 | 1.42 Million USD | 238.72% |
| 2020 Q3 | -6.2 Million USD | -160.67% |
| 2020 Q4 | -4.55 Million USD | 26.54% |
| 2020 FY | 20.16 Million USD | 6669.38% |
| 2020 Q1 | 20.7 Million USD | 0.0% |
| 2020 Q2 | 10.22 Million USD | -50.59% |
| 2019 FY | -307 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| America Great Health | 168.58 Thousand USD | 13694.681% |
| Ampio Pharmaceuticals, Inc. | -250 Thousand USD | -9067.6% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -4059.528% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -12775.843% |
| Better Therapeutics, Inc. | -2.72 Million USD | -739.831% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -1554.801% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 5521.895% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Evolutionary Genomics, Inc. | -1.02 Million USD | -2143.677% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -223.167% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -8749.035% |
| Innovation1 Biotech Inc. | -52.69 Thousand USD | -43391.214% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -719.736% |
| Molecular Templates, Inc. | 50.39 Million USD | 145.479% |
| Navidea Biopharmaceuticals, Inc. | -119.29 Thousand USD | -19112.037% |
| NexImmune, Inc. | -1.02 Million USD | -2136.061% |
| Orgenesis Inc. | -5.72 Million USD | -300.332% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 10.637% |
| Point of Care Nano-Technology, Inc. | -4601.00 USD | -498030.841% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 177.99% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -4593.496% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -9778.879% |
| Trevena, Inc. | 1.45 Million USD | 1675.189% |
| Vaxxinity, Inc. | -2.23 Million USD | -925.918% |
| Vaccinex, Inc. | -16 Million USD | -43.208% |
| Vicapsys Life Sciences, Inc. | - USD | Infinity% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -4558.333% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 197507.407% |